Neurotensin and Its Receptors Mediate Neuroendocrine Transdifferentiation in Prostate Cancer

Oncogene - United Kingdom
doi 10.1038/s41388-019-0750-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Ventral Midbrain NTS1 Receptors Mediate Conditioned Reward Induced by the Neurotensin Analog, D-Tyr[11]neurotensin

Frontiers in Neuroscience
Neuroscience
2015English

Oncogenic Role of Neurotensin and Neurotensin Receptors in Various Cancers

Clinical and Experimental Pharmacology and Physiology
PhysiologyPharmacology
2017English

Models of Neuroendocrine Prostate Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2014English

Targeting Neuropeptide Receptors for Cancer Imaging and Therapy: Perspectives With Bombesin, Neurotensin, and Neuropeptide-Y Receptors

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2014English

Molecular Model for Neuroendocrine Prostate Cancer Progression

BJU International
Urology
2018English

Is HOTAIR Really Involved in Neuroendocrine Prostate Cancer Differentiation?

Epigenomics
Cancer ResearchGenetics
2018English

Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?

Frontiers in Oncology
Cancer ResearchOncology
2015English

Inhibition of Neurotensin Receptor 1 Selectively Sensitizes Prostate Cancer to Ionizing Radiation

Cancer Research
Cancer ResearchOncology
2011English

MA22.02 Activation of MAPK Suppresses Neuroendocrine Transcription Factors and Causes Transdifferentiation of Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy